Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 99 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
981 11.7 months Castration-resistant prostate cancer 4 Chemotherapy
University of Michigan United States 12/2009
Treatment Details: Patients: This phase II study involved 27 men with metastatic castration-resistance prostate cancer who had been previously treated with chemotherapy. The median age was 68 years. Treat
 
982 11.7 months metastatic breast cancer 4 Chemotherapy
German Breast Group Germany 1/2005
Treatment Details: Patients: This Phase II study involved 58 women with metastatic breast cancer. The mean age was 54.2 years. Metastatic sites included liver, bone lung, and lymph nodes. All patients had p
 
983 11.7 months Hormone-refractory prostate cancer 4 Chemotherapy
Rudolfstiftung Austria 1/2004
Treatment Details: Patients: This Phase II study involved a total of 90 patients with hormone refractory prostate cancer. Patients were divided into two groups of 45 patients each: Group 1 and Group 2. T
 
984 11.7 months Advanced colorectal cancer 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 3/2004
Treatment Details: Patients: This Phase I trial involved 71 patients with advanced colorectal cancer. Treatment: Treatment consisted of two chemotherapy drugs raltitrexed (Tomudex) and 5-fluorouracil (5-
 
985 11.7 months Advanced colorectal cancer 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 3/2004
Treatment Details: Patients: This Phase I trial involved 71 patients with advanced colorectal cancer. Treatment: Treatment consisted of two chemotherapy drugs raltitrexed (Tomudex) and 5-fluorouracil (5-
 
986 11.6 months Newly diagnosed GBM 5 Chemotherapy
Radiation
Johns Hopkins Oncology Center United States 1/2004
Treatment Details: Patients: This Phase II study involved 55 patients with newly diagnosed glioblastoma multiforme. Treatment: Treatment consisted of the drug suramin and radiotherapy. Toxicity: One pati
 
987 11.6 months Castration-resistant prostate cancer 4 Biologic therapy
Norris Comprehensive Cancer Center United States 6/2010
Treatment Details: Patients: This phase II study involved 53 men with castration-resistant prostate cancer who had received previous chemotherapy. The median patient age was 71 years. Treatment: Patients
 
988 11.6 months metastatic breast cancer 4 Chemotherapy
University of Texas MD Anderson Cancer Center United States 11/2008
Treatment Details: Patients: This phase 2 study involved 50 women with metastatic breast cancer. The median age was 50, ranging from 26 to 73 years of age. Treatment: Patients were treated with the chemot
 
989 11.6 months colorectal (advanced) 5 Chemotherapy
Southampton General Hospital United Kingdom 8/2006
Treatment Details: Patients: This phase II study involved 22 patients with advanced colorectal cancer. The median age was 64, ranging from 27 to 75 years. Fifteen were men and seven were women. Treatment
 
990 11.6 months metastatic melanoma 4 Chemotherapy
Univeristy Hospital Ehrlangen Germany 1/2006
Treatment Details: Patients: This phase III study involved a total of 108 patients with metastatic melanoma. Patients were divided into two groups. Group A had 55 patients and Group B had 53 patients. Ther
 
Page 99 of 187  | Previous Page  | Next Page